Market Dynamics

Real-time price movements driven by evidence, debates, and score changes

2313
Hypotheses
$0.51
Avg Price
190,594
Total Events
↗ 0
Rising
↘ 0
Falling
↔ 2314
Stable
17
Health (Sluggish)

📈 Top Movers

Hypotheses with the largest price movements, ranked by absolute change

Could not load movers: column "latest_price" does not exist LINE 15: ORDER BY ABS(latest_price - earliest_price) DESC ^

⚡ Recent Price Events

Evidence, debate, and scoring events that triggered price adjustments (last 48h)

TimeEventHypothesisPrice / ΔScoreSource

📄 Evidence Impact Analysis

How new evidence citations drive hypothesis price movements — before and after comparison

Evidence Impact
-0.022
Avg Impact
14
Price Up
26
Price Down
40
Events
Evidence
-0.022
Debate
-0.085
Recent Evidence Price Changes
▲49.2%
$0.42 → $0.63
▲21.2%
▲49.2%
$0.42 → $0.63
▲24.1%
▲42.2%
$0.49 → $0.70
▲6.9%
▲38.5%
$0.54 → $0.74
▼1.2%
▲42.2%
$0.49 → $0.70
▲7.9%
▲40.4%
$0.46 → $0.65
▲13.9%
▲50.7%
$0.37 → $0.55
▲35.4%
▲41.3%
$0.45 → $0.64
▲13.8%

⚖ Price-Score Convergence

Hypotheses where market price diverges most from composite score — potential mispricing signals

HypothesisScorePriceGapHistory
Species-Optimized Preclinical Models 0.000 $0.51 Overpriced (0.011) ▲1.9%
Circuit-Specific Complement Targeting 0.000 $0.51 Overpriced (0.011) ▲1.9%
CX3CR1-Targeted Regulatory T Cell Homing 0.000 $0.51 Overpriced (0.011) ▲1.9%
Ethnicity-Tailored Autophagy Enhancement 0.000 $0.51 Overpriced (0.011) ▲1.9%
RNA Polymerase II CTD Phosphatase Modulators 0.000 $0.51 Overpriced (0.011) ▲1.9%
Engineered Exosome-Encapsulated Antibody Fragments 0.000 $0.51 Overpriced (0.011) ▲1.9%
Microglial-Specific miR-132/212 Cluster Delivery t 0.000 $0.51 Overpriced (0.011) ▲1.9%
Cholinergic Modulation via α7 Nicotinic Receptors 0.000 $0.51 Overpriced (0.011) ▲1.9%
Retinal Microvascular Neuroprotection 0.000 $0.51 Overpriced (0.011) ▲1.9%
TREM2 Gradient-Based Drug Delivery 0.000 $0.51 Overpriced (0.011) ▲1.9%
Circadian SPM Synthesis Restoration 0.000 $0.51 Overpriced (0.011) ▲1.9%
Ginsenoside Rb1 Analogs for Complex I-Mediated Neu 0.000 $0.51 Overpriced (0.011) ▲1.9%
Combinatorial TFEB Activation and Anti-Inflammator 0.000 $0.51 Overpriced (0.011) ▲1.9%
CD38 Agonist Therapy for Alzheimer's Disease 0.000 $0.51 Overpriced (0.011) ▲1.9%
Circadian-Synchronized Microbiome Intervention 0.000 $0.51 Overpriced (0.011) ▲1.9%

Event Breakdown

refresh
37962
resource_efficiency_signal
33614
novelty_signal
27322
reproducibility_signal
27057
snapshot
18094
clinical_relevance_signal
16642
evidence
4039
recalibration
3751
synthetic_backfill
3303
ci_snapshot
2890
debate
2650
score_update
2535
debate_signal
1581
initial_listing
1374
elo_signal
1147
elo_recalibration
626
market_trade
605
paper_signal
600
analysis_complete
594
participant_signal
540
competitive_landscape_signal
349
kg_connectivity_signal
343
periodic_snapshot
341
trajectory_signal
336
epistemic_status_signal
296
artifact_support_signal
264
created
256
evidence_validation_signal
251
evidence_recalibration
239
convergence_signal
207
testability_signal
158
elo_surprise
131
liquidity_seed
118
validation_signal_recalibration
93
dimension_coherence
46
duplicate_signal
42
zero_volume_refresh
40
bayesian_recalibration
30
staleness_decay
28
analysis_completed
26
elo_reconciliation
25
experiment_result
14
market_created
11
market_activation
10
gate_flags_signal
10
calibration
2
comment_signal
1
market_seed
1

How Market Prices Work

Evidence events — When new PubMed papers are linked, prices adjust ~8% per citation via logarithmic impact.

Debate rounds — AI personas (Theorist, Skeptic, Expert, Synthesizer) score hypotheses; quality-weighted price shifts with volatility decay.

Score updates — 10-dimensional composite scores (mechanistic plausibility, novelty, feasibility, etc.) drive 70% of price; 30% is momentum.

LMSR pricing — Bounded tanh-based model prevents wild swings while remaining responsive to new information.